146 related articles for article (PubMed ID: 12500092)
1. In vivo excitotoxicity induced by ouabain, a Na+/K+-ATPase inhibitor.
Veldhuis WB; van der Stelt M; Delmas F; Gillet B; Veldink GA; Vliegenthart JF; Nicolay K; Bär PR
J Cereb Blood Flow Metab; 2003 Jan; 23(1):62-74. PubMed ID: 12500092
[TBL] [Abstract][Full Text] [Related]
2. Status of the neonatal rat brain after NMDA-induced excitotoxic injury as measured by MRI, MRS and metabolic imaging.
Dijkhuizen RM; van Lookeren Campagne M; Niendorf T; Dreher W; van der Toorn A; Hoehn-Berlage M; Verheul HB; Tulleken CA; Leibfritz D; Hossmann KA; Nicolay K
NMR Biomed; 1996 Apr; 9(2):84-92. PubMed ID: 8887373
[TBL] [Abstract][Full Text] [Related]
3. [3H]dizocilpine binding to N-methyl-D-aspartate (NMDA) receptor is modulated by an endogenous Na+, K+-ATPase inhibitor. Comparison with ouabain.
Reinés A; Peña C; Rodríguez de Lores Arnaiz G
Neurochem Int; 2001 Oct; 39(4):301-10. PubMed ID: 11551670
[TBL] [Abstract][Full Text] [Related]
4. Changes in the diffusion of water and intracellular metabolites after excitotoxic injury and global ischemia in neonatal rat brain.
Dijkhuizen RM; de Graaf RA; Tulleken KA; Nicolay K
J Cereb Blood Flow Metab; 1999 Mar; 19(3):341-9. PubMed ID: 10078886
[TBL] [Abstract][Full Text] [Related]
5. Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na-/K(+)-ATPase in brain tissue in vitro.
Nanitsos EK; Acosta GB; Saihara Y; Stanton D; Liao LP; Shin JW; Rae C; Balcar VJ
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):762-9. PubMed ID: 15566390
[TBL] [Abstract][Full Text] [Related]
6. Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus.
Kawamoto EM; Lima LS; Munhoz CD; Yshii LM; Kinoshita PF; Amara FG; Pestana RR; Orellana AM; Cipolla-Neto J; Britto LR; Avellar MC; Rossoni LV; Scavone C
J Neurosci Res; 2012 Jan; 90(1):213-28. PubMed ID: 22006678
[TBL] [Abstract][Full Text] [Related]
7. Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+ -ATPase inhibitor.
Bersier MG; Miksztowicz V; Peña C; Rodríguez de Lores Arnaiz G
Neurochem Res; 2005 Apr; 30(4):479-86. PubMed ID: 16076019
[TBL] [Abstract][Full Text] [Related]
8. Na
Kurauchi Y; Noma K; Hisatsune A; Seki T; Katsuki H
J Pharmacol Sci; 2018 Nov; 138(3):167-175. PubMed ID: 30322800
[TBL] [Abstract][Full Text] [Related]
9. Na+,K+-ATPase functionally interacts with the plasma membrane Na+,Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress.
Sibarov DA; Bolshakov AE; Abushik PA; Krivoi II; Antonov SM
J Pharmacol Exp Ther; 2012 Dec; 343(3):596-607. PubMed ID: 22927545
[TBL] [Abstract][Full Text] [Related]
10. Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-dependent transport in spinal cord white matter.
Li S; Stys PK
Neuroscience; 2001; 107(4):675-83. PubMed ID: 11720790
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of [3H]dizocilpine binding to N-methyl-D-aspartate receptor by an endogenous Na+, K+-ATPase inhibitor: dependence on receptor activation.
Reinés A; Peña C; Rodríguez de Lores Arnaiz G
Brain Res; 2004 Jan; 996(1):117-25. PubMed ID: 14670638
[TBL] [Abstract][Full Text] [Related]
12. Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo.
Golden WC; Martin LJ
Neuroscience; 2006; 137(1):133-44. PubMed ID: 16297565
[TBL] [Abstract][Full Text] [Related]
13. Hypothermia and metabolic stress: narrowing the cellular site of early neuroprotection.
Zeevalk GD; Nicklas WJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):332-9. PubMed ID: 8859011
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptor involvement in phosphoinositide hydrolysis stimulation by an endogenous Na(+), K(+)-ATPase inhibitor and ouabain in neonatal rat brain.
Calviño MA; Peña C; Rodríguez de Lores Arnaiz G
Brain Res Dev Brain Res; 2002 Oct; 138(2):167-75. PubMed ID: 12354644
[TBL] [Abstract][Full Text] [Related]
15. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology.
van Lookeren Campagne M; Verheul JB; Nicolay K; Balázs R
J Cereb Blood Flow Metab; 1994 Nov; 14(6):1011-23. PubMed ID: 7929643
[TBL] [Abstract][Full Text] [Related]
16. Interactions between excitotoxins and the Na+/K+-ATPase inhibitor ouabain in causing neuronal lesions in the rat hippocampus.
Lees GJ; Leong W
Brain Res; 1996 Apr; 714(1-2):145-55. PubMed ID: 8861619
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity.
van der Stelt M; Veldhuis WB; Bär PR; Veldink GA; Vliegenthart JF; Nicolay K
J Neurosci; 2001 Sep; 21(17):6475-9. PubMed ID: 11517236
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase.
Silva VS; Nunes MA; Cordeiro JM; Calejo AI; Santos S; Neves P; Sykes A; Morgado F; Dunant Y; Gonçalves PP
Toxicology; 2007 Jul; 236(3):158-77. PubMed ID: 17560001
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
[TBL] [Abstract][Full Text] [Related]
20. Creatine increases hippocampal Na(+),K(+)-ATPase activity via NMDA-calcineurin pathway.
Rambo LM; Ribeiro LR; Schramm VG; Berch AM; Stamm DN; Della-Pace ID; Silva LF; Furian AF; Oliveira MS; Fighera MR; Royes LF
Brain Res Bull; 2012 Sep; 88(6):553-9. PubMed ID: 22742935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
